Abstract

Introduction: Rhinocerebral Mucormycosis (RCM) has been challenging infection specially occurring in diabetic and immunocompromised patients. Its clinical manifestation varies from mild cases to very severe fatal infection with toxemia and septicemia. Especially in the background of covid 19 RCM infections has increased drastically. Aims and objectives: We are proposing novel grading system for RCM which can help to categorize these patients and provide systemic treatment guidelines as per their stage Patients and methods: From the patients that have attended GCS medical college and hospital with diagnosis of RCM we have classified them in to grade I to grade IV according to their clinical and radiological findings and as per their local or systemic symptoms. Results: We could classify the patients and accordingly the treatment and approach could be planned. Prognosis can also be explained from their grades.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call